These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 7694290

  • 1. Increasing cAMP attenuates activation of mitogen-activated protein kinase.
    Sevetson BR, Kong X, Lawrence JC.
    Proc Natl Acad Sci U S A; 1993 Nov 01; 90(21):10305-9. PubMed ID: 7694290
    [Abstract] [Full Text] [Related]

  • 2. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
    Lowe WL, Fu R, Banko M.
    Endocrinology; 1997 Jun 01; 138(6):2219-26. PubMed ID: 9165004
    [Abstract] [Full Text] [Related]

  • 3. Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin.
    Chaudhary LR, Avioli LV.
    Mol Cell Biochem; 1998 Jan 01; 178(1-2):59-68. PubMed ID: 9546582
    [Abstract] [Full Text] [Related]

  • 4. Cyclic AMP-mediated inhibition of angiotensin II-induced protein synthesis is associated with suppression of tyrosine phosphorylation signaling in vascular smooth muscle cells.
    Giasson E, Servant MJ, Meloche S.
    J Biol Chem; 1997 Oct 24; 272(43):26879-86. PubMed ID: 9341120
    [Abstract] [Full Text] [Related]

  • 5. Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts.
    Siddhanti SR, Hartle JE, Quarles LD.
    Endocrinology; 1995 Nov 24; 136(11):4834-41. PubMed ID: 7588214
    [Abstract] [Full Text] [Related]

  • 6. The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor.
    Calleja V, Ruiz Enríquez P, Filloux C, Peraldi P, Baron V, Van Obberghen E.
    Endocrinology; 1997 Mar 24; 138(3):1111-20. PubMed ID: 9048617
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, Raf-1, and MAP kinase kinase.
    Bird TA, Kyriakis JM, Tyshler L, Gayle M, Milne A, Virca GD.
    J Biol Chem; 1994 Dec 16; 269(50):31836-44. PubMed ID: 7527398
    [Abstract] [Full Text] [Related]

  • 8. MAP kinase stimulation by cAMP does not require RAP1 but SRC family kinases.
    Klinger M, Kudlacek O, Seidel MG, Freissmuth M, Sexl V.
    J Biol Chem; 2002 Sep 06; 277(36):32490-7. PubMed ID: 12082090
    [Abstract] [Full Text] [Related]

  • 9. Cyclic AMP stimulates the phosphorylation and activation of p42 and p44 mitogen-activated protein kinases in 3T3-F442A preadipocytes.
    Yarwood SJ, Kilgour E, Anderson NG.
    Biochem Biophys Res Commun; 1996 Jul 25; 224(3):734-9. PubMed ID: 8713115
    [Abstract] [Full Text] [Related]

  • 10. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase.
    De Fea K, Roth RA.
    J Biol Chem; 1997 Dec 12; 272(50):31400-6. PubMed ID: 9395471
    [Abstract] [Full Text] [Related]

  • 11. Parietal cell MAP kinases: multiple activation pathways.
    Nakamura K, Zhou CJ, Parente J, Chew CS.
    Am J Physiol; 1996 Oct 12; 271(4 Pt 1):G640-9. PubMed ID: 8897883
    [Abstract] [Full Text] [Related]

  • 12. cAMP inhibits the insulin-stimulated mitogen-activated protein kinase pathway in rat hepatoma H4EII cells.
    Nagasaka Y, Kaku K, Nakamura K, Kaneko T.
    Biochem Biophys Res Commun; 1994 Jul 29; 202(2):1104-12. PubMed ID: 8048924
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
    Tamir A, Granot Y, Isakov N.
    J Immunol; 1996 Aug 15; 157(4):1514-22. PubMed ID: 8759733
    [Abstract] [Full Text] [Related]

  • 14. Regulation of lysophosphatidic acid-stimulated tyrosine phosphorylation of pp42 mitogen-activated protein kinase by protein kinase C and protein kinase A in EAhy926 cells.
    McLees A, Graham A, Malarkey K, Gould GW, Plevin R.
    Biochem Soc Trans; 1995 May 15; 23(2):339S. PubMed ID: 7545616
    [No Abstract] [Full Text] [Related]

  • 15. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
    Luo W, Sharif TR, Houghton PJ, Sharif M.
    Cell Growth Differ; 1997 Nov 15; 8(11):1225-40. PubMed ID: 9372245
    [Abstract] [Full Text] [Related]

  • 16. MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway.
    Ai W, Gong J, Yu L.
    FEBS Lett; 1999 Jul 30; 456(1):196-200. PubMed ID: 10452557
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of mammalian target of rapamycin activity by increased cAMP in 3T3-L1 adipocytes.
    Scott PH, Lawrence JC.
    J Biol Chem; 1998 Dec 18; 273(51):34496-501. PubMed ID: 9852118
    [Abstract] [Full Text] [Related]

  • 18. Phosphorylation of mitogen-activated protein kinase is regulated by protein kinase C, cyclic 3',5'-adenosine monophosphate, and protein phosphatase modulators during meiosis resumption in rat oocytes.
    Lu Q, Smith GD, Chen DY, Yang Z, Han ZM, Schatten H, Sun QY.
    Biol Reprod; 2001 May 18; 64(5):1444-50. PubMed ID: 11319150
    [Abstract] [Full Text] [Related]

  • 19. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.
    Ariga M, Nedachi T, Akahori M, Sakamoto H, Ito Y, Hakuno F, Takahashi S.
    Biochem J; 2000 Jun 01; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436
    [Abstract] [Full Text] [Related]

  • 20. Mitogen-activated protein kinase-dependent stimulation of proliferation of rat lactotrophs in culture by 3',5'-cyclic adenosine monophosphate.
    Suzuki S, Yamamoto I, Arita J.
    Endocrinology; 1999 Jun 01; 140(6):2850-8. PubMed ID: 10342877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.